Free Trial

Equifax (EFX) Stock Forecast & Price Target

Equifax logo
$265.04
-4.28 (-1.59%)
(As of 10/31/2024 ET)

Equifax - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
4
Buy
16

Based on 20 Wall Street analysts who have issued ratings for Equifax in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 20 analysts, 4 have given a hold rating, and 16 have given a buy rating for EFX.

Consensus Price Target

$310.47
17.14% Upside
According to the 20 analysts' twelve-month price targets for Equifax, the average price target is $310.47. The highest price target for EFX is $380.00, while the lowest price target for EFX is $267.00. The average price target represents a forecasted upside of 17.14% from the current price of $265.04.
Get the Latest News and Ratings for EFX and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Equifax and its competitors.

Sign Up

EFX Analyst Ratings Over Time

TypeCurrent Forecast
11/1/23 to 10/31/24
1 Month Ago
10/2/23 to 10/1/24
3 Months Ago
8/3/23 to 8/2/24
1 Year Ago
11/1/22 to 11/1/23
Strong Buy
0 Strong Buy rating(s)
1 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
16 Buy rating(s)
15 Buy rating(s)
14 Buy rating(s)
7 Buy rating(s)
Hold
4 Hold rating(s)
4 Hold rating(s)
3 Hold rating(s)
5 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$310.47$305.11$287.00$215.19
Forecasted Upside17.14% Upside5.10% Upside0.77% Upside28.31% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Hold

EFX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EFX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Equifax Stock vs. The Competition

TypeEquifaxBusiness Services CompaniesS&P 500
Consensus Rating Score
2.80
2.68
2.50
Consensus RatingModerate BuyModerate BuyHold
Predicted Upside15.55% Upside317.93% Upside9.72% Upside
News Sentiment Rating
Positive News

See Recent EFX News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/28/2024Needham & Company LLC
2 of 5 stars
 Reiterated RatingBuy ➝ Buy$350.00 ➝ $350.00+29.68%
10/18/2024Wells Fargo & Company
3 of 5 stars
J. Haas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
10/18/2024Robert W. Baird
2 of 5 stars
 Boost TargetOutperform ➝ Outperform$290.00 ➝ $333.00+18.01%
10/18/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$300.00 ➝ $304.00+7.88%
10/8/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$300.00 ➝ $315.00+10.26%
10/1/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
K. Mcveigh
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$360.00+22.51%
9/19/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Grobler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderperform ➝ Neutral$310.00+4.18%
9/13/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$300.00 ➝ $380.00+24.12%
9/12/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$250.00 ➝ $271.00-9.05%
8/20/2024The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral ➝ Neutral$277.00 ➝ $307.00+4.23%
7/24/2024Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$263.00 ➝ $304.00+15.32%
7/19/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$265.00 ➝ $305.00+15.45%
7/18/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$255.00 ➝ $286.00+10.34%
7/9/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Wurtzel
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform$275.00+13.97%
2/13/2024Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeIn-Line ➝ Outperform$210.00 ➝ $310.00+21.21%
2/9/2024Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$270.00 ➝ $285.00+14.38%
1/11/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$272.00+11.10%
12/18/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$200.00 ➝ $315.00+28.78%
12/8/2023Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$218.00 ➝ $267.00+19.05%
11/17/2023Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform
7/21/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$235.00 ➝ $250.00+15.54%
11/15/2022Atlantic Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeNeutral ➝ Overweight$230.00+16.21%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:16 PM ET.


Should I Buy Equifax Stock? EFX Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, October 18, 2024. Please send any questions or comments about these Equifax pros and cons to contact@marketbeat.com.

Equifax
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Equifax Inc.:

  • Equifax Inc. reported higher-than-expected EPS for the quarter, indicating strong financial performance.
  • The company's revenue for the quarter exceeded consensus estimates, showing positive growth.
  • Equifax Inc. has a healthy net margin of 10.67% and a return on equity of 18.88%, reflecting efficient operations and profitability.
  • Recent insider selling by EVP Carla Chaney could indicate confidence in the company's future performance.
  • Equifax Inc. has received positive ratings from analysts, with price targets indicating potential growth.

Equifax
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Equifax Inc. for these reasons:

  • The dividend payout ratio of Equifax Inc. is currently at 34.74%, which may limit potential reinvestment for growth.
  • Despite positive analyst ratings, there is always a level of uncertainty in the market that could impact stock performance.
  • Recent insider selling activity, such as EVP Carla Chaney selling shares, could raise concerns about future prospects.
  • Market conditions and regulatory changes in the credit services industry could affect Equifax Inc.'s operations and profitability.
  • Investors should carefully monitor any developments related to data breaches or cybersecurity risks that could impact Equifax Inc.'s reputation and financial stability.

EFX Forecast - Frequently Asked Questions

According to the research reports of 20 Wall Street equities research analysts, the average twelve-month stock price forecast for Equifax is $310.47, with a high forecast of $380.00 and a low forecast of $267.00.

20 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Equifax in the last year. There are currently 4 hold ratings and 16 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" EFX shares.

According to analysts, Equifax's stock has a predicted upside of 17.14% based on their 12-month stock forecasts.

Over the previous 90 days, Equifax's stock had 2 upgrades by analysts.

Analysts like Equifax more than other "business services" companies. The consensus rating score for Equifax is 2.80 while the average consensus rating score for "business services" companies is 2.68. Learn more on how EFX compares to other companies.


This page (NYSE:EFX) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners